OpenBilldrug price receipt

NADAC week of 2026-10-14

OMEPRAZOLE-BICARB 20-1,100 CAP

For 30 capsules

Pharmacies pay

$18.86 filed

30 × $0.62862 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$858.37 filed

30 × $28.61243 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

45.5× estimated

These two figures may not measure the same thing

At 45.5×, the Medicare figure is 20 or more times what pharmacies pay. A gap that large means the two figures may not describe the same unit or product, or the price may have changed between their dates; check what each one covers before relying on the multiple.

Part D averages every strength and form sold under “Omeprazole-Sodium Bicarbonate” / “Omeprazole/Sodium Bicarbonate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$26.69 estimated

$18.86 + $2.83 (15%) + $5.00 fee per fill = $26.69

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

OMEPRAZOLE-BICARB 20-1,100 CAP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “omeprazole and sodium bicarbonate” and “omeprazole sodium bicarbonate”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as capsule and its route as oral.

Its labelers, the companies named on the label, are Ajanta Pharma USA Inc. and Cipla USA Inc.

FDA’s Established Pharmacologic Class for it is Proton Pump Inhibitor.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes); the FDA directory lists 2 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $18.86 for 30 capsules (30 × $0.62862 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

All 3 NDCs

Other strengths, forms and brands

4 other products in the NADAC file share an FDA nonproprietary name with OMEPRAZOLE-BICARB 20-1,100 CAP.

ProductPharmacies pay per unitMedicare per unit
KONVOMEP 2-84 MG/ML ORAL SUSP
brand · kit
$1.2442 to $2.085 per ML filed
eff. 2026-09-23
$1.40677 per ML filed
Part D 2024 average
OMEPRAZOLE-BICARB 20-1,100 CAP this page
generic · capsule
$0.62862 per EA filed
eff. 2026-09-23
$28.61243 per EA filed
Part D 2024 average
OMEPRAZOLE-BICARB 20-1,680 PKT
generic · for suspension / powder, for suspension
$8.11251 per EA filed
eff. 2026-09-23
$28.61243 per EA filed
Part D 2024 average
OMEPRAZOLE-BICARB 40-1,100 CAP
generic · capsule / capsule, gelatin coated
$0.56222 per EA filed
eff. 2026-09-23
$28.61243 per EA filed
Part D 2024 average
OMEPRAZOLE-BICARB 40-1,680 PKT
generic · for suspension / powder, for suspension
$7.90411 per EA filed
eff. 2026-09-23
$28.61243 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 3 NDCs’ NADAC prices is $0.62862 per EA filed.

Of the 61 other products in FDA’s Proton Pump Inhibitor class priced per EA, 33 have a higher middle NADAC price and 28 a lower one. The one in the middle is LANSOPRAZOLE DR 30 MG ODT, at $2.25583 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $858.37 for 30 capsules, at an average of $28.61243 per EA in 2024 (2024-01-01 to 2024-12-31) for “Omeprazole-Sodium Bicarbonate” and “Omeprazole/Sodium Bicarbonate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 93,925 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

1 of the product’s 3 NDCs have this Medicare figure; the other 2 do not, and the interactive card says why for each.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for OMEPRAZOLE-BICARB 20-1,100 CAP labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Omeprazole-Sodium Bicarbonate / Omeprazole/Sodium Bicarbonate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.